Protein folding activity of ribosomal rna is a selective target of two unrelated antiprion drugs
Tribouillard-Tanvier, DéborahINSERM U613, Brest, France - Univ Brest, Faculté de Médecine et des Sciences de la Santé, UMR-S613, Brest, France - Etablissement Français du Sang (EFS) Bretagne, Brest, France - CHU Brest, Hop Morvan, Laboratoire de Génétique Moléculaire, Brest, France - CNRS UPS2682, Station Biologique, Protein Phosphorylation & Disease Laboratory, Roscoff, France
Reis, Suzana DosInstitute of Cell and Molecular Biology, Uppsala University, Sweden
Gug, FabienneINSERM U648, Laboratoire de Chimie Organique 2, Université Paris Descartes, France
Voisset, CécileINSERM U613, Brest, France - Univ Brest, Faculté de Médecine et des Sciences de la Santé, UMR-S613, Brest, France - Etablissement Français du Sang (EFS) Bretagne, Brest, France - CHU Brest, Hop Morvan, Laboratoire de Génétique Moléculaire, Brest, France
Béringue, VincentInstitut National de la Recherche Agronomique (INRA), UR892, Virologie Immunologie Moléculaires, Jouy-en-Josas, France
Sabate, RaimonLaboratoire de Génétique Moléculaire des Champignons, IBGC UMR CNRS 5095, Université de Bordeaux 2, France
Kikovska, EmaInstitute of Cell and Molecular Biology, Uppsala University, Sweden
Talarek, NicolasDepartment of Medicine/Biochemistry, University of Fribourg, Switzerland
Bach, StéphaneCNRS UPS2682, Station Biologique, Protein Phosphorylation & Disease Laboratory, Roscoff, France
Huang, ChenhuiInstitute of Cell and Molecular Biology, Uppsala University, Sweden
Desban, NathalieCNRS UPS2682, Station Biologique, Protein Phosphorylation & Disease Laboratory, Roscoff, France
Saupe, Sven J.Laboratoire de Génétique Moléculaire des Champignons, IBGC UMR CNRS 5095, Université de Bordeaux 2, France
Supattapone, SurachaiDepartment of Medicine, Dartmouth Medical School, Hanover, New Hampshire, USA - Department of Biochemistry, Dartmouth Medical School, Hanover, New Hampshire, USA
Vilette, DidierInstitut National de la Recherche Agronomique (INRA), UR892, Virologie Immunologie Moléculaires, Jouy-en-Josas, France
Galons, HervéINSERM U648, Laboratoire de Chimie Organique 2, Université Paris Descartes, France
Sanyal, SuparnaInstitute of Cell and Molecular Biology, Uppsala University, Sweden
Blondel, MarcINSERM U613, Brest, France - Univ Brest, Faculté de Médecine et des Sciences de la Santé, UMR-S613, Brest, France - Etablissement Français du Sang (EFS) Bretagne, Brest, France - CHU Brest, Hop Morvan, Laboratoire de Génétique Moléculaire, Brest, France
English
Background: 6-Aminophenanthridine (6AP) and Guanabenz (GA, a drug currently in use for the treatment of hypertension) were isolated as antiprion drugs using a yeast-based assay. These structurally unrelated molecules are also active against mammalian prion in several cell-based assays and in vivo in a mouse model for prion-based diseases.Methodology/Principal Findings: Here we report the identification of cellular targets of these drugs. Using affinity chromatography matrices for both drugs, we demonstrate an RNA-dependent interaction of 6AP and GA with the ribosome. These specific interactions have no effect on the peptidyl transferase activity of the ribosome or on global translation. In contrast, 6AP and GA specifically inhibit the ribosomal RNA-mediated protein folding activity of the ribosome.Conclusion/Significance: 6AP and GA are therefore the first compounds to selectively inhibit the protein folding activity of the ribosome. They thus constitute precious tools to study the yet largely unexplored biological role of this protein folding activity.